Filing search / Phathom Pharmaceuticals, Inc. / "Access" / Page 4

8-K

8mv3l5zs9j zeec

18 Oct 21

Results of Operations and Financial Condition

7:06am

424B5

vgc2v lc7bq27a98

17 Dec 20

Prospectus supplement for primary offering

4:29pm

8-K

EX-1.1

soicr6v25dn5

17 Dec 20

Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock

4:26pm

424B5

safje

15 Dec 20

Prospectus supplement for primary offering

5:19pm

S-3

EX-1.2

0u0xwyggs2u8pn

10 Nov 20

Shelf registration

5:17pm

S-3

4qahplwnml qddm

10 Nov 20

Shelf registration

5:17pm

8-K

EX-99.1

ifr xvvhx766d1

10 Nov 20

Phathom Pharmaceuticals Reports Third Quarter 2020 Results and Provides Update on Phase 3 Trials

4:06pm

8-K

EX-3.1

nrar6fl l0mhak7y

25 Sep 20

Amendments to Articles of Incorporation or Bylaws

4:05pm

DEFA14A

ztvfs

8 Apr 20

Additional proxy soliciting materials

11:36am

DEF 14A

u97cqj4fi 66x

8 Apr 20

Definitive proxy

8:31am